Skip to main content

Abstract

As reported in the guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver, the use of CEUS is recommended for the following indications [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX, World Federation for Ultrasound in Medicine (2013) European Federation of Societies for Ultrasound. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative incooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39(2):187–210. doi:10.1016/j.ultrasmedbio.2012.09.002

    Article  PubMed  Google Scholar 

  2. Kudo M, Okanoue T (2007) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72(Suppl 1):2–15

    Article  PubMed  Google Scholar 

  3. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M (2011) Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29:339–364

    Article  PubMed  Google Scholar 

  4. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed Central  PubMed  Google Scholar 

  5. Barreiros AP, Piscaglia F, Dietrich CF (2012) Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 57(4):930–2. doi:10.1016/j.jhep.2012.04.018

  6. Konopke R, Bunk A, Kersting S (2008) Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy. Ultraschall Med 29(Suppl 4):S203–S209

    Article  PubMed  Google Scholar 

  7. Chen MH, Yang W, Yan K, Zou MW, Solbiati L, Liu JB, Dai Y (2004) Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients–mathematic model, overlapping mode, and electrode placement process. Radiology 232:260–271

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bartolotta, T.V., Taibbi, A., Midiri, M. (2015). Impact of European Guidelines on CEUS. In: Atlas of Contrast-enhanced Sonography of Focal Liver Lesions. Springer, Cham. https://doi.org/10.1007/978-3-319-17539-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17539-3_7

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17538-6

  • Online ISBN: 978-3-319-17539-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics